Skip to content
We're attending Nordic Life Science Days in Copenhagen, Oct 13-14 - Reach out to us in the partnering system!
Meet us at OCT New England 2025 in Boston, Oct 15-16 - Booth #71
We’re attending ESMO 2025 in Berlin, Oct 17-21
  • News & Insights
  • CAREERS
  • RFP

MLM ONLINE ®

Search
MLM Medical Labs
  • Meet MLM
    • About
    • Leadership
    • Global Reach
    • Africa’s Trial Market
      • Cytespace Africa Labs
      • Africa’s Trial Landscape
    • Quality
    • News & Insights
  • Services
    • Preclinical
      • Preclinical Overview
      • Cell Culture Modeling
      • In-Vivo Models
        • Fibrosis Models
    • Specialty Testing and Translational
      • Global Access to PBMCs
      • Assay Development and Validation
      • Harmonized Flow Cytometry
      • Biomarkers in Alzheimer’s
      • Cell and Gene Therapy
      • Animal Nutrition & Feed Research
      • Medical Device Support
    • Histology
      • Immunostaining IHC/IF
      • Digital Pathology
      • Histology Gallery
    • Central lab services
      • Central Lab Overview
      • Operational Excellence
      • Safety Lab Testing
      • Study Set Up
      • Data Management
      • Global Logistics
      • Infectious Disease Trials
    • MLM Kit Building®
      • MLM Kit Building®
      • MLM Safeguard Box®
    • Sample processing and Management
      • MLM Kit Building®
      • mlm online®
      • Dry Blood Spot Collection
      • Sample Analysis
      • Point of Collection Tracking
  • Analytical Overview
    • Immunoassays
    • Platelet Function Assays
    • Multiplex Assays
    • Enzymatic Assays
    • Coagulation
    • Flow Cytometry
    • RT-PCR
    • HPLC
    • CELL-BASED Assays
    • Histology
  • Assay Menu
  • Resources
    • Knowledge Library
    • Unit Converter
    • Histology Image Gallery
  • Contact
    • Contact Us
    • Request For Proposals
    • Your Feedback
    • Subscribe
    • Locations
  • News & Insights
  • CAREERS
  • RFP

MLM ONLINE ®

Search
MLM Medical Labs
  • Meet MLM
    • About
    • Leadership
    • Global Reach
    • Africa’s Trial Market
      • Cytespace Africa Labs
      • Africa’s Trial Landscape
    • Quality
    • News & Insights
  • Services
    • Preclinical
      • Preclinical Overview
      • Cell Culture Modeling
      • In-Vivo Models
        • Fibrosis Models
    • Specialty Testing and Translational
      • Global Access to PBMCs
      • Assay Development and Validation
      • Harmonized Flow Cytometry
      • Biomarkers in Alzheimer’s
      • Cell and Gene Therapy
      • Animal Nutrition & Feed Research
      • Medical Device Support
    • Histology
      • Immunostaining IHC/IF
      • Digital Pathology
      • Histology Gallery
    • Central lab services
      • Central Lab Overview
      • Operational Excellence
      • Safety Lab Testing
      • Study Set Up
      • Data Management
      • Global Logistics
      • Infectious Disease Trials
    • MLM Kit Building®
      • MLM Kit Building®
      • MLM Safeguard Box®
    • Sample processing and Management
      • MLM Kit Building®
      • mlm online®
      • Dry Blood Spot Collection
      • Sample Analysis
      • Point of Collection Tracking
  • Analytical Overview
    • Immunoassays
    • Platelet Function Assays
    • Multiplex Assays
    • Enzymatic Assays
    • Coagulation
    • Flow Cytometry
    • RT-PCR
    • HPLC
    • CELL-BASED Assays
    • Histology
  • Assay Menu
  • Resources
    • Knowledge Library
    • Unit Converter
    • Histology Image Gallery
  • Contact
    • Contact Us
    • Request For Proposals
    • Your Feedback
    • Subscribe
    • Locations

News

MLM Memphis in New England Journal of Medicine

Our Navigators are pleased to announce the publication of “Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers” in the latest edition of the New England Journal of Medicine. CirQuest founder and CSO MLM Medical Labs, Dr. Lisa K.

Jennings, worked with trailblazing partners from the Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Thomas Jefferson University, the Thrombosis and Atherosclerosis Research Institute, and PhaseBio Pharmaceuticals to co-author this fascinating study. Visit NEJM to read the publication.

Post navigation
← Previous Post
Next Post →

© 2025 MLM Medical Labs

  • Editorial Information
  • Privacy Policy
Subscribe to mlm newsletter